Screener/Healthcare/Biotechnology

MAZE

Maze Therapeutics, Inc.NASDAQ
$48.78-0.12 (-0.24%)
Mid CapUnder $50HealthcareHigh Beta
$6.71
$53.65
$46.06
$49.25
EPS (TTM)$-2.58
P/E Ratio—
Dividend Yield—
Market Cap$2.17B
Volume379K
Prev Close$49.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$30.1M$-0.66——
Q2 '25$0-$33.7M$-0.77——
Q1 '25$0-$32.8M$-1.15——
Get Your Daily Market Recap